Please login to bookmark Close

A shareholder class action alleges Cochlear knew months before announcing a profit downgrade that weakening US demand, financial pressures on hospitals and problems with its new Nexa implant made its FY26 earnings guidance unreliable.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au